The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.
Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy
Abstract
Autophagy is fundamental to the maintenance of intracellular homeostasis in virtually all human cells. Accordingly, defective autophagy predisposes healthy cells to undergoing malignant transformation. By contrast, malignant cells are able to harness autophagy to thrive, despite adverse microenvironmental conditions, and to resist therapeutic challenges. Thus, inhibition of autophagy has been proposed as a strategy to kill cancer cells or sensitize them to therapy; however, autophagy is also critical for optimal immune function, and mediates cell-extrinsic homeostatic effects owing to its central role in danger signalling by neoplastic cells responding to immunogenic chemotherapy and/or radiation therapy. In this Perspective, we discuss accumulating preclinical and clinical evidence in support of the all-too-often dismissed possibility that activating autophagy might be a relevant clinical objective that enables an increase in the effectiveness of immunogenic chemotherapy and/or radiation therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ICD can be initiated by a relatively restricted set of stimuli, including viral infection, some FDA-approved chemotherapeutics (e.g., anthracyclines, bortezomib), specific forms of radiation therapy, and hypericin-based photodynamic therapy [854–861].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [856]
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, R. C., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,214
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,444
Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy
Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X. H., Mizushima, N., Packer, M., Schneider, M. D., & Levine, B. (2005) · Cell · doi:10.1016/j.cell.2005.07.002 · Cited by 3,536
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Self-citationThe role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Self-citationMechanism and medical implications of mammalian autophagy
Dikic, I., & Elazar, Z. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0003-4 · Cited by 2,771
Macrophages and metabolism in the tumor microenvironment
Vitale, I., Manic, G., Coussens, L. M., Kroemer, G., & Galluzzi, L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.001 · Cited by 1,837
Self-citationMolecular definitions of autophagy and related processes
Galluzzi, L., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cecconi, F., Choi, A. M., Chu, C. T., Codogno, P., Colombo, M. I., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201796697 · Cited by 1,646
Self-citationAutophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationMitochondrial metabolism and cancer
Porporato, P. E., Filigheddu, N., Pedro, J. M. B., Kroemer, G., & Galluzzi, L. (2017) · Cell Research · doi:10.1038/cr.2017.155 · Cited by 1,323
Self-citationThe Roles of Autophagy in Cancer
Yun, C. W., & Lee, S. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113466 · Cited by 965
Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
Galluzzi, L., Bravo-San Pedro, J. M., Levine, B., Green, D. R., & Kroemer, G. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.22 · Cited by 842
Self-citationTang, T., Huang, X., Zhang, G., Hong, Z., Bai, X., & Liang, T. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00449-4 · Cited by 618
Lactate: A Metabolic Driver in the Tumour Landscape
Ippolito, L., Morandi, A., Giannoni, E., & Chiarugi, P. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.10.011 · Cited by 541
Linking cellular stress responses to systemic homeostasis
Galluzzi, L., Yamazaki, T., & Kroemer, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0068-0 · Cited by 556
Self-citationLactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 545
Zhou, J., Li, M., Hou, Y., Luo, Z., Chen, Q., Cao, H., Huo, R., Xue, C., Sutrisno, L., Hao, L., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00309 · Cited by 424
The spectrum of T cell metabolism in health and disease
Bantug, G. R., Galluzzi, L., Kroemer, G., & Hess, C. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.99 · Cited by 436
Self-citationAutophagy and cancer stem cells: molecular mechanisms and therapeutic applications
Nazio, F., Bordi, M., Cianfanelli, V., Locatelli, F., & Cecconi, F. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0292-y · Cited by 395
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
Yamazaki, T., Kirchmair, A., Sato, A., Buqué, A., Rybstein, M., Petroni, G., Bloy, N., Finotello, F., Stafford, L., Navarro Manzano, E., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0751-0 · Cited by 359
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Liu, Y., Zhang, P., Li, F., Jin, X., Li, J., Chen, W., & Li, Q. (2018) · Theranostics · doi:10.7150/thno.22172 · Cited by 335
Wang, L., Guan, R., Xie, L., Liao, X., Xiong, K., Rees, T. W., Chen, Y., Ji, L., & Chao, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202013987 · Cited by 294
The autophagic network and cancer
Rybstein, M. D., Pedro, J. M. B., Kroemer, G., & Galluzzi, L. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0042-2 · Cited by 294
Self-citationTrial watch: Immunogenic cell death induction by anticancer chemotherapeutics
Garg, A. D., More, S., Rufo, N., Meçe, O., Sassano, M. L., Agostinis, P., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1386829 · Cited by 288
Self-citationZhou, L., Zhai, M., Huang, Y. H., Xu, S., An, T., Wang, Y.-H., Zhang, R., Liu, C.-Y., Dong, Y.-H., Wang, M., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0206-4 · Cited by 253
Li, R., Li, Z., Leng, X., Li, H., Ma, Y., Chen, Y., & Song, F. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109726 · Cited by 250
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Guo, S., Yao, Y., Tang, Y., Xin, Z., Wu, D., Ni, C., Huang, J., Wei, Q., & Zhang, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01462-z · Cited by 290
WNT Signaling in Cancer Immunosurveillance
Galluzzi, L., Spranger, S., Fuchs, E. V., & López‐Soto, A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.08.005 · Cited by 245
Self-citationTrial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
Vanmeerbeek, I., Sprooten, J., Ruysscher, D. D., Tejpar, S., Vandenberghe, P., Fucikova, J. P., Špíšek, R., Zitvogel, L., Kroemer, G., Galluzzi, L., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2019.1703449 · Cited by 231
Self-citationSonodynamic therapy-derived multimodal synergistic cancer therapy
Xu, M., Zhou, L., Zheng, L., Zhou, Q., Liu, K., Mao, Y., & Song, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.10.037 · Cited by 211
Autophagy in stem cells: repair, remodelling and metabolic reprogramming
Boya, P., Codogno, P., & Rodriguez-Muela, N. (2018) · Development · doi:10.1242/dev.146506 · Cited by 197
Photodynamic Therapy and Immunity: An Update
Falk‐Mahapatra, R., & Gollnick, S. O. (2020) · Photochemistry and Photobiology · doi:10.1111/php.13253 · Cited by 201
Gremke, N., Polo, P., Dort, A., Schneikert, J., Elmshäuser, S., Brehm, C. U., Klingmüller, U., Schmitt, A., Reinhardt, H. C., Timofeev, O. N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18504-7 · Cited by 192
IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer
Kania, E., Roest, G., Vervliet, T., Parys, J. B., & Bultynck, G. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00140 · Cited by 169
Autophagy and intermittent fasting: the connection for cancer therapy?
Antunes, F., Erustes, A. G., Costa, A. J., Nascimento, A. C., Bincoletto, C., Ureshino, R. P., Pereira, G. J. S., & Smaili, S. S. (2018) · Clinics · doi:10.6061/clinics/2018/e814s · Cited by 179
Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment
Petroni, G., Buqué, A., Coussens, L. M., & Galluzzi, L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00415-5 · Cited by 162
Self-citationRadiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
Walle, T., Kraske, J. A., Liao, B., Lenoir, B., Timke, C., Halbach, E. V. B. U., Tran, F., Griebel, P., Albrecht, D., Ahmed, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abh4050 · Cited by 159
Research progress on morphology and mechanism of programmed cell death
Chen, Y., Li, X., Yang, M., & Liu, S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06712-8 · Cited by 168
Recent Insights into the Mitochondrial Role in Autophagy and Its Regulation by Oxidative Stress
Agujetas, V. R., de Dios, C., Pinilla, L. L., Marı́, M., Morales, A., & Colell, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3809308 · Cited by 153
Jabir, M. S., Saleh, Y. M., Sulaiman, G. M., Yaseen, N. Y., Sahib, U. I., Dewir, Y. H., Alwahibi, M. S., & Soliman, D. A. (2021) · Nanomaterials · doi:10.3390/nano11020384 · Cited by 143
Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy
Radogna, F., & Diederich, M. F. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.006 · Cited by 146
D’Amico, L., Menzel, U., Prummer, M., Müller, P., Buchi, M., Kashyap, A. S., Haessler, U., Yermanos, A., Gébleux, R., Briendl, M., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0464-1 · Cited by 133
Lin, J., Wang, W., Hu, T., Zhu, G., Li, L.-N., Zhang, C.-Y., Xu, Z., Yu, H.-B., Wu, H., & Zhu, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.014 · Cited by 136
circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637
Zhang, Y., Li, C., Liu, X., Wang, Y., Zhao, R., Yang, Y., Zheng, X. M., Zhang, Y., & Zhang, X. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.051 · Cited by 135
NF‐κB targeting for overcoming tumor resistance and normal tissues toxicity
Mortezaee, K., Najafi, M., Farhood, B., Ahmadi, A., Shabeeb, D., & Musa, A. E. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28504 · Cited by 130
Ivermectin, a potential anticancer drug derived from an antiparasitic drug
Tang, M., Hu, X., Wang, Y., Yao, X., Zhang, W., Yu, C., Cheng, F., Li, J., & Fang, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105207 · Cited by 133
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications
Buqué, A., Bloy, N., Aranda, F., Castoldi, F., Eggermont, A. M. M., Cremer, I., Fridman, W. H., Fucikova, J. P., Galon, J., Marabelle, A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008814 · Cited by 132
Self-citationTargeting autophagy in cancer stem cells as an anticancer therapy
Lei, Y., Zhang, D., Yu, J., Dong, H. F., Zhang, J., & Yang, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.012 · Cited by 127
Progress of engineered bacteria for tumor therapy
Fan, J., Niu, M., Qin, Y., Sun, Y., & Zhang, X. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114296 · Cited by 126
Autophagy and Hallmarks of Cancer
Huang, T., Song, X., Yang, Y., Wan, X., Alvarez, A. A., Sastry, N. G., Feng, H., Hu, B., & Cheng, S. (2018) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2018027913 · Cited by 120
Targeting regulated cell death in tumor nanomedicines
Zeng, Q., Ma, X., Song, Y., Chen, Q., Jiao, Q., & Zhou, L. (2021) · Theranostics · doi:10.7150/thno.67932 · Cited by 120
Rapamycin inhibits proliferation and induces autophagy in human neuroblastoma cells
Lin, X., Han, L., Weng, J., Wang, K., & Chen, T. (2018) · Bioscience Reports · doi:10.1042/bsr20181822 · Cited by 110
Wang, X., Lan, Z., He, J., Lai, Q., Yao, X., Li, Q., Liu, Y., Lai, H., Gu, C.-C., Yan, Q., et al. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0951-6 · Cited by 108
Autophagy: Supporting cellular and organismal homeostasis by self-eating
Eskelinen, E. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.03.010 · Cited by 110
The role of Wnt signaling pathway in tumor metabolic reprogramming
Mo, Y., Wang, Y., Zhang, L., Yang, L., Zhou, M., Li, X., Li, Y., Li, G., Zeng, Z., Xiong, W., et al. (2019) · Journal of Cancer · doi:10.7150/jca.31166 · Cited by 106
Bloy, N., Garcia, P., Laumont, C. M., Pitt, J. M., Sistigu, A., Stoll, G., Yamazaki, T., Bonneil, É., Buqué, A., Humeau, J., et al. (2017) · Immunological Reviews · doi:10.1111/imr.12582 · Cited by 106
Self-citationHypoxia-driven intratumor heterogeneity and immune evasion
Terry, S., Engelsen, A. S. T., Buart, S., El‐Sayed, W., Venkatesh, G. H., & Chouaı̈b, S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.004 · Cited by 102
Mardi, A., Shirokova, A. V., Mohammed, R. N., Keshavarz, A., Zekiy, A. O., Thangavelu, L. P., Mohammad, T. A. M., Marofi, F., Shomali, N., Zamani, A., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02585-z · Cited by 102
The Role of Decorin and Biglycan Signaling in Tumorigenesis
Diehl, V., Huber, L. S., Trebicka, J., Wygrecka, M., Iozzo, R. V., & Schaefer, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.801801 · Cited by 100
Zhou, Y., Shao, Y., Hu, W., Zhang, J., Shi, Y., Kong, X., & Jiang, J. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01049-1 · Cited by 93
Huang, Y., You, X., Wang, L., Zhang, G., Gui, S., Jin, Y., Zhao, R., & Zhang, D. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202001906 · Cited by 93
Xu, Q., Zhang, H., Liu, H., Han, Y., Qiu, W., & Li, Z. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121287 · Cited by 91
Melatonin transport into mitochondria
Mayo, J. C., Sainz, R. M., González‐Menéndez, P., Hevia, D., & Cernuda‐Cernuda, R. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2616-8 · Cited by 93
Janji, B., Berchem, G., & Chouaı̈b, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00887 · Cited by 86
Xu, C., Yu, Y., Sun, Y., Kong, L., Yang, C., Hu, M. Y., Yang, T., Zhang, J., Hu, Q., & Zhang, Z. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201905213 · Cited by 84
Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2‐mediated autophagy
Fang, L., Lv, J., Xuan, Z., Li, B., Li, Z., He, Z., Li, F., Xu, J., Wang, S., Xia, Y., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.708 · Cited by 85
Granato, M., Montani, M. S. G., Santarelli, R., D’Orazi, G., Faggioni, A., & Cirone, M. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0632-z · Cited by 83
HAMdb: a database of human autophagy modulators with specific pathway and disease information
Wang, N.-N., Dong, J., Zhang, L., Ouyang, D., Cheng, Y., Chen, A. F., Lu, A.-P., & Cao, D.-S. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0289-4 · Cited by 83
Autophagy modulation: a prudent approach in cancer treatment?
Bishop, E., & Bradshaw, T. D. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3669-6 · Cited by 87
Hu, Y. B., Zhang, H., Dong, L., Xu, M., Zhang, L., Ding, W., Zhang, J., Lin, J., Zhang, Y., Qiu, B., et al. (2019) · Nanoscale · doi:10.1039/c8nr08442d · Cited by 83
Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy
Yu, C. H. A., Yang, B., & Najafi, M. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13648 · Cited by 78
Zhang, N., Peng, F., Wang, Y., Li, Y., Wu, F., Wang, X., Cui, Y., Han, B., & He, G. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.36955 · Cited by 77
Sun, Y., Huang, Y., Huang, F., Mei, W.-L., Liu, Q., Wang, C.-C., Lin, Y., Huang, C., Li, Y., Dai, H., et al. (2018) · Theranostics · doi:10.7150/thno.23304 · Cited by 74
Immune oncology, immune responsiveness and the theory of everything
Turan, T., Kannan, D., Patel, M. R., Barnes, J. M., Tanlimco, S. G., Lu, R. O., Halliwill, K. D., Kongpachith, S., Kline, D. E., Hendrickx, W., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0355-5 · Cited by 76
Autophagy in natural and therapy-driven anticancer immunosurveillance
Pietrocola, F., Pedro, J. M. B., Galluzzi, L., & Kroemer, G. (2017) · Autophagy · doi:10.1080/15548627.2017.1310356 · Cited by 75
Self-citationTrial watch: immune checkpoint blockers for cancer therapy
Vanpouille-Box, C., Lhuillier, C., Bezu, L., Aranda, F., Yamazaki, T., Kepp, O., Fucikova, J., Spisek, R., Demaria, S., Formenti, S. C., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1373237 · Cited by 73
Niklaus, M., Adams, O. J., Berezowska, S., Zlobec, I., Graber, F., Slotta‐Huspenina, J., Nitsche, U., Rosenberg, R., Tschan, M. P., & Langer, R. (2017) · Oncotarget · doi:10.18632/oncotarget.17554 · Cited by 72
Jia, J., Zhang, H., Shi, Q., Yang, C., Ma, J., Jin, B., Wang, X., He, D., & Guo, P. (2019) · Theranostics · doi:10.7150/thno.33282 · Cited by 71
Wu, J., Yu, J., Wang, J., Zhang, C., Shang, K., Yao, X., & Cao, B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.140 · Cited by 70
Vehlow, A., Klapproth, E., Jin, S., Hannen, R., Hauswald, M., Bartsch, J. W., Nimsky, C., Temme, A., Leitinger, B., & Cordes, N. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.096 · Cited by 70
Potentiating prostate cancer immunotherapy with oncolytic viruses
Lee, P. C., & Gujar, S. A. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2018.10 · Cited by 70
Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
Meltzer, S., Bjørnetrø, T., Lyckander, L. G., Flatmark, K., Dueland, S., Samiappan, R., Johansen, C., Kalanxhi, E., Ree, A. H., & Redalen, K. R. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.04.014 · Cited by 68
Xu, W., Yu, M., Qin, J., Luo, Y., & Zhong, M. (2020) · Cancer Management and Research · doi:10.2147/cmar.s250661 · Cited by 68
Cell death pathologies: targeting death pathways and the immune system for cancer therapy
Pentimalli, F., Grelli, S., Daniele, N. D., Melino, G., & Amelio, I. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0052-x · Cited by 69
Induction of immunogenic cell death in cancer cells by a photoactivated platinum( iv ) prodrug
Novohradský, V., Prachařová, J., Kašpárková, J., Imberti, C., Bridgewater, H. E., Sadler, P. J., & Brabec, V. (2020) · Inorganic Chemistry Frontiers · doi:10.1039/d0qi00991a · Cited by 67
Cell damage produced by magnetic fluid hyperthermia on microglial BV2 cells
Calatayud, M. P., Soler, E., Torres, T. E., González, E. C., Junquera, C., Ibarra, M. R., & Goya, G. F. (2017) · Scientific Reports · doi:10.1038/s41598-017-09059-7 · Cited by 66
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Cirone, M., Montani, M. S. G., Granato, M., Garufi, A., Faggioni, A., & D’Orazi, G. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1275-z · Cited by 65
Therapeutic modulation of autophagy: which disease comes first?
Maiuri, M. C., & Kroemer, G. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0290-0 · Cited by 66
Self-citationRahman, M. A., Saha, S. K., Rahman, M. S., Uddin, M. J., Uddin, M. S., Pang, M., Rhim, H., & Cho, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00283 · Cited by 61
Zhou, H., Gong, X., Lin, H., Chen, H., Huang, D., Li, D., Shan, H., & Gao, J. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02390e · Cited by 63
The use of African medicinal plants in cancer management
Gaobotse, G., Venkataraman, S., Brown, P. D., Masisi, K., Kwape, T. E., Nkwe, D. O., Rantong, G., & Makhzoum, A. B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1122388 · Cited by 68
Sun, Q., Yang, J., Shen, W. H., Lu, H., Hou, X., Liu, Y., Xu, Y., Wu, Q., Xuan, Z., Yang, Y., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121796 · Cited by 61
The role of radiation induced oxidative stress as a regulator of radio-adaptive responses
Sisakht, M., Darabian, M., Mahmoodzadeh, A., Bazı, A., Shafiee, S. M., Mokarram, P., & Khoshdel, Z. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1721597 · Cited by 60
Molecular determinants of immunogenic cell death elicited by radiation therapy
Galassi, C., Klapp, V., Yamazaki, T., & Galluzzi, L. (2023) · Immunological Reviews · doi:10.1111/imr.13271 · Cited by 65
Self-citationTrial Watch: Immunostimulation with recombinant cytokines for cancer therapy
García-Martínez, E., Smith, M. M., Buqué, A., Aranda, F., de la Peña, F. A., Rubio, A. I., Cánovas, M. S., Conesa, M. A. V., Fucikova, J. P., Špíšek, R., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1433982 · Cited by 56
Self-citationXia, C., Li, M., Ran, G., Wang, X., Lu, Z., Li, T., Tang, X., Zhang, Z., & He, Q. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.034 · Cited by 55
TRPM2-AS promotes cancer cell proliferation through control of TAF15
Li, P., Li, Y., Jin, L., Li, J., & Xu, A. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105683 · Cited by 54
Zheng, J., Wang, B., Zheng, R., Zhang, J., Huang, C., Zheng, R., Huang, Z., Qiu, W., Liu, M., Yang, K., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02977-x · Cited by 54
Masuelli, L., Granato, M., Benvenuto, M., Mattera, R., Bernardini, R., Mattei, M., d’Amati, G., D’Orazi, G., Faggioni, A., Bei, R., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1356151 · Cited by 52
Epigenetic targeting of autophagy for cancer prevention and treatment by natural compounds
Vidoni, C., Ferraresi, A., Secomandi, E., Vallino, L., Dhanasekaran, D. N., & Isidoro, C. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.04.006 · Cited by 54
Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
Sridharan, S., Howard, C. M., Tilley, A. M. C., Subramaniyan, B., Tiwari, A. K., Ruch, R. J., & Raman, D. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01003 · Cited by 54
Zhou, L., Huo, M., Qian, X., Ding, L., Yu, L., Feng, W., Cui, X., & Chen, Y. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00855-y · Cited by 53
The interplay between autophagy and cGAS-STING signaling and its implications for cancer
Schmid, M., Fischer, P., Engl, M., Widder, J., Gruber, S., & Slade, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1356369 · Cited by 61
Metadata
- Authors
- Galluzzi, L., Bravo-San Pedro, J. M., Demaria, S., Formenti, S. C., & Kroemer, G.
- Affiliations
- Inserm (FR)
- Weill Cornell Medicine (US)
- Karolinska University Hospital (SE)
- Corresponding author
- Galluzzi, Lorenzo
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2016-11-15
- Volume
- 14
- Issue
- 4
- Pages
- 247-258
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2549172728
- Cited by
- 314
- References
- 126
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 22 · 2023: 36 · 2022: 36 · 2021: 30 · 2020: 43 · 2019: 45 · 2018: 43 · 2017: 30 · 2016: 1
- FWCI
- 5.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA198533, R01CA161891, R01CA201246)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- autophagy, autophagy activation, immunogenic chemotherapy, radiotherapy, cancer immunotherapy, antitumor immunity, autophagy inhibition, tumor microenvironment, tumor immunosuppression
- MeSH terms
- Autophagy, Clinical Trials as Topic, Forecasting, Humans, Immunotherapy, Neoplasms, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review